Market Access

Access Matters: The rise of the payer and implications for pharma

In a two-part series exclusive to Pharmafield, Neil Grubert and Mel Walker, Managing Director at Biopharma Futures, explore key trends in international market access....
New data dimensions: virtual and augmented reality in life sciences

Virtual and augmented reality in life sciences

Just as engineers in complex physical environments might use enhanced visualisation to gain a clearer understanding of a technical problem, or shoppers might use...
Demystifying the NHS White Paper - a Representative's position

Demystifying the NHS White Paper – a representative’s position

With the release of the NHS White Paper, Star OUTiCO caught up with their Market Access Multi-Channel Account Manager, Steve Meadows, to get his...
New NHS operational planning guidance – what does it mean for pharma?

New NHS operational planning guidance – what does it mean for pharma?

Why is the new NHS operational planning guidance so significant and what does it mean for pharmaceutical companies? Oli Hudson, Content Director at Wilmington...
Pf Awards 2021 – responding to the pandemic

Pf Awards 2021 – responding to the pandemic

The introduction of a new Pf Awards category for 2021 - Responsive Company Strategy - gave insight into companies who specifically demonstrated a rapid,...
What does it really take to conduct a vaccine trial at scale?

What does it really take to conduct a vaccine trial at scale?

The Pfizer/BioNTech COVID-19 vaccine trial was one of the largest and fastest clinical trials ever conducted. ICON, a global provider of outsourced drug and...
COVID-19 and the impact on heart failure care

COVID-19 and the impact on heart failure care

As the coronavirus pandemic continues to strain healthcare services in the UK, findings from the first patient survey into the impact of COVID-19 on...
Talking heads - what can pharma learn from 2020?

Talking heads – what can pharma learn from 2020?

  As we enter a new year and a next normal, taking time to reflect on the challenges and opportunities that 2020 presented to pharma...
The future of clinical research

The future of clinical research

Clinical research is the most expensive and often most time-consuming phase of drug development. This fact puts huge commercial pressures on businesses and, in...
Bringing in change with Brexit

Bringing in change with Brexit

With a post-Brexit deal agreed, it is time to weigh up the opportunities and the risks for industry. From clinical trials to marketing authorisation,...

Latest articles

Non-nurses being hired to work as nurses in hospitals and mental health facilities, RCN warns

Non-nurses being hired as nurses in hospitals and mental health facilities, RCN warns

The RCN is warning against growing instances of people without registered nurse qualifications being employed for registered nursing roles and compromising patient safety. The RCN...
Pf talks to Simon Nicholson, MD of Organon, the global women's health company

Pf talks to Simon Nicholson, MD of Organon

It is long overdue, but women’s health is finally having its moment in the spotlight and it feels like there could be a big...
High street pharmacies making their inventory visible on Google

High street pharmacies making their inventory visible on Google

Over 400 high street pharmacies will now be better equipped to drive online shoppers in-store, by making their inventory visible on Google in real-time. With...

Popular articles

Market Access

Access Matters: The rise of the payer and implications for pharma

In a two-part series exclusive to Pharmafield, Neil Grubert and Mel Walker, Managing Director at Biopharma Futures, explore key trends in international market access....
Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Pf talks to Simon Nicholson, MD of Organon, the global women's health company

Pf talks to Simon Nicholson, MD of Organon

It is long overdue, but women’s health is finally having its moment in the spotlight and it feels like there could be a big...
High street pharmacies making their inventory visible on Google

High street pharmacies making their inventory visible on Google

Over 400 high street pharmacies will now be better equipped to drive online shoppers in-store, by making their inventory visible on Google in real-time. With...
PHE confirms coronavirus Delta variant is now dominant in the UK

PHE confirms coronavirus Delta variant is now dominant in the UK

The weekly coronavirus update released by Public Health England (PHE) has shown that cases of the Delta (VOC-21APR-02) variant in the UK have risen...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription